1. We have studied the modulation of volume-regulated anion channels (VRACs) by the small GTPase Rho and by one of its targets, Rho kinase, in calf pulmonary artery endothelial (CPAE) cells. 2. RT-PCR and immunoblot analysis showed that both RhoA and Rho kinase are expressed in CPAE cells. 3. ICl,swell, the chloride current through VRACs, was activated by challenging CPAE cells with a 25% hypotonic extracellular solution (HTS) or by intracellular perfusion with a pipette solution containing 100 ìÒ GTPãS.
Pretreatment of CPAE cells with the Clostridium C2IN-C3 fusion toxin, which inactivatesRho by ADP ribosylation, significantly impaired the activation of ICl,swell in response to the HTS. The current density at +100 mV was 49 ± 13 pA pF¢ (n = 17) in pretreated cells compared with 172 ± 17 pA pF¢ (n = 21) in control cells. 5. The volume-independent activation of ICl,swell by intracellular perfusion with GTPãS was also impaired in C2IN-C3-pretreated cells (31 ± 7 pA pF¢, n = 11) compared with nontreated cells (132 ± 21 pA pF¢, n = 15). 6. Activation of ICl,swell was pertussis toxin (PTX) insensitive. 7. Y_27632, a blocker of Rho kinase, inhibited ICl,swell and delayed its activation. 8. Inhibition of Rho and of Rho kinase by the above-described treatments did not affect the extent of cell swelling in response to HTS. 9. These experiments provide strong evidence that the Rho-Rho kinase pathway is involved in the VRAC activation cascade.